跳转至内容
Merck
CN

63184

伊红-5-马来酰亚胺

suitable for fluorescence, ≥93% (HPLC)

别名:

EMA, 伊红-5-马来酰亚胺

登录 查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C24H9Br4NO7
化学文摘社编号:
分子量:
742.95
MDL编号:
UNSPSC代码:
12352207
PubChem化学物质编号:
NACRES:
NA.32
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

质量水平

方案

≥93% (HPLC)

表单

powder

分子量

742.95 g/mol

颜色

light orange to dark orange
light red

荧光

λex 524 nm; λem 545 nm (after derivatization with 2-mercaptoethanol)

适用性

suitable for fluorescence

储存温度

2-8°C

SMILES字符串

Oc1c(Br)cc2c(Oc3c(Br)c(O)c(Br)cc3C24OC(=O)c5cc(ccc45)N6C(=O)C=CC6=O)c1Br

InChI

1S/C24H9Br4NO7/c25-13-6-11-21(17(27)19(13)32)35-22-12(7-14(26)20(33)18(22)28)24(11)10-2-1-8(5-9(10)23(34)36-24)29-15(30)3-4-16(29)31/h1-7,32-33H

InChI key

YRCLWXRIEYQTAV-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

5-马来酰亚胺-伊红,也称为 EMA 或伊红-5-马来酰亚胺,是一种荧光结合剂。5-马来酰亚胺-伊红结合试验可测量 EMA 标记细胞减少的平均通道荧光(MCF)读数。

应用

伊红-5-马来酰亚胺已被用作人红细胞带 3 蛋白的荧光探针。 它被广泛用作实验室诊断探针,以通过流式细胞术检测遗传性球形红细胞增多症(HS)。 伊红-5-马来酰亚胺结合试验已用于分析阿勒替尼(一线治疗)对于变性淋巴瘤激酶(ALK)的效果。

其他说明

三重探针。测量蛋白质在溶液和膜中的旋转扩散,包括肌球蛋白和丙酮酸脱氢酶

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type N95 (US)


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

A J Visser et al.
European journal of biochemistry, 121(1), 233-235 (1981-12-01)
The enzymatically reduced lipoyl residues of the transacetylase component of the pyruvate dehydrogenase complex from Escherichia coli were labeled with eosin maleimide. Using eosin as triplet probe, triplet-triplet absorption dichroism measurements were performed to obtain rotational correlation times of the
S Ishiwata et al.
The Journal of biological chemistry, 262(17), 8314-8317 (1987-06-15)
We studied the rotational Brownian motions of myosin heads, of which the sulfhydryl group was selectively labeled with the triplet probe 5-eosinylmaleimide, in myofibril by using flash-induced phosphorescence anisotropy decay measurements. The anisotropy decay curve under relaxing conditions consisted of
P Joshi et al.
International journal of laboratory hematology, 38(5), 520-526 (2016-06-25)
Laboratory diagnosis of hereditary spherocytosis (HS) relies on increased incubated red cell osmotic fragility test for screening. We evaluated the diagnostic role of eosin-5'-maleimide (EMA) binding test by flow cytometry in spherocytic and microcytic hypochromic hematological disorders in North Indians.
Linda Hunt et al.
Cytometry. Part B, Clinical cytometry, 88(1), 50-57 (2014-09-18)
The eosin-5'-maleimide (EMA) Binding test measures reduced mean channel fluorescence (MCF) reading of EMA-labeled red cells (EMA-RBCs) from patients with hereditary spherocytosis (HS). Reporting test results can be either in the actual MCF reading or as a ratio by normalization
James A Kuzich et al.
Pathology, 53(5), 608-612 (2021-02-24)
We reviewed haematological investigations for 43 patients treated at a single centre with alectinib, an inhibitor of anaplastic lymphoma kinase (ALK) which is considered standard first-line treatment for patients with ALK-rearranged advanced non-small cell lung cancer. Ninety-five percent of patients

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持